Novartis' (NOVN SW/NVS) Ianalumab receives FDA breakthrough therapy designation for Sjögren’s disease and plans global submission in early 2026
Novartis has received FDA breakthrough therapy designation for Ianalumab to treat Sjögren’s disease, which indicates a significant validation of its potential and may accelerate its path to market.
US reportedly explores plan to swap heavy Venezuelan oil for US medium crude to fill SPR, according to reports
US Treasury reportedly considering quarterly 7-year note auctions with reopening's
Novartis' (NOVN SW/NVS) Ianalumab receives FDA breakthrough therapy designation for Sjögren’s disease and plans global submission in early 2026
Venezuelan opposition leader Machado will not reveal details of conversation with Trump and did insist on returning to Venezuela as soon as possible
US President Trump says he had a great meeting on Healthcare this morning, government money must be paid, not to the insurance companies, but directly to the people; Healthcare will be provided at a substantially reduced cost
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
The plan for a global submission by early 2026 suggests confidence in regulatory support, potentially enhancing Novartis's competitive position in the pharmaceuticals sector. This development could positively affect investor sentiment and expectations regarding pipeline growth and future revenues.
Related headlines
- Daily US Equity Opening News: ORCL gains on earnings and FY guidance beat; ADBE weighed by slight Q4 revenue miss; SMR downgraded2 days ago
- Burry adds to his positions in Zoetis (ZTS) and Lululemon (LULU); sold entire position in Flutter (FLUT)1 day ago
- Newsquawk Daily European Equity Opening News - 11th September 20262 days ago
- EU regulators are reportedly set to issue a formal warning over MMG's USD 500mln deal to buy Anglo American's (AAL LN) Brazilian nickel assets, the FT reports2 days ago
- [MARKET ANALYSIS] European bourses benefit from cooling energy prices, US equity futures eye CPI data2 days ago
- Newsquawk US Market Wrap: Markets chop, and yields flatten after hot core CPI boosts Fed rate hike bets1 day ago
- US FX WRAP: Dollar sees two-way action, but initially firms on hotter-than-expected core M/M print2 days ago
- SNB's Schlegel says inflation has recently ticker higher2 days ago
- [PREVIEW] Swedish General Election on 13th September 2026; prelim results due around 20:00 BST1 hour ago
- Newsquawk Weekly US Earnings Estimates: 14-18th September 2026: LEN the only earning all week1 day ago
- Corning (GLW) files for a USD 2bln common stock offering of up to USD 2.0bln1 day ago
- Astra Zeneca (AZN LN) Serena 4 trial (Phase 3) did not meet primary endpoint of PFS for treatment of Breast Cancer 1 day ago
- Saudi Arabia has signaled a potential willingness to launch a major unilateral military operation against the Houthis, though Riyadh has not yet reached a final decision, according to ABC2 days ago
- TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLE 8 TICKS LOWER AT 106-03+2 days ago
- US President Trump reiterates USD 5k payment to all US adults will happen 2 days ago
- Google (GOOGL) just completed its USD 1.5bln-plus deal for AI startup Mechanize, reports Business Insider2 days ago
- CRUDE WRAP: WTI (V6) SETTLES USD 2.43 LOWER AT 100.05/BBL; BRENT (X6) SETTLES USD 3.02 LOWER AT 104.61/BBL2 days ago
- Estee Lauder (EL) reportedly advances against Walmart (WMT) over knockoffs, according to Bloomberg Law2 days ago
- Situational Awareness builds relationships with new brokers as it attempts rebound, reports FT; is rebuilding large trading positions in stocks such as AMD (AMD), Intel (INTC), SK Hynix (SHY), Sandisk (SNDK) and Coreweave (CRWV)2 days ago
- A high-ranking Iranian security and political source told Al Mayadeen that contrary to claims and intimidation tactics, US President Trump is seeking to return to negotiations with Iran2 days ago
The whole workspace, free to try.
Try it free